Dayal Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.61 M
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 Cr
- Revenue Growth -5.60%
- Profit Growth -3.62%
- Ebitda 38.59%
- Net Worth 2.13%
- Total Assets 1.96%
About Dayal Biotech
Dayal Biotech Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 1988 and has a history of 36 years and seven months. Its registered office is in Meerut, Uttar Pradesh, India.
The Corporate was formerly known as Himalaya Chemicals P Ltd. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.61 M.
The company has closed loans amounting to ₹4.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aman Kumar, Amrita Kumar, Geeta Kumar, and One other member serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899UP1988PTC123472
- Company No.
123472
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Dayal Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman Kumar  | Director | 01-Aug-2016 | Current |
| Amrita Kumar | Director | 26-Nov-2019 | Current |
| Geeta Kumar | Director | 16-Jan-2006 | Current |
| Abhay Gupta | Director | 26-Jul-1988 | Current |
Financial Performance of Dayal Biotech.
Dayal Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.6% decrease. The company also saw a slight decrease in profitability, with a 3.62% decrease in profit. The company's net worth moved up by a moderate rise of 2.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dayal Biotech?
In 2023, Dayal Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dayal Vet Foods Private LimitedAbhay Gupta is a mutual person
Dayal Seeds Private LimitedAman Kumar, Amrita Kumar and 1 more are mutual person
Dayal Infosystems Private LimitedAman Kumar and Abhay Gupta are mutual person
Dayal Industries Private LimitedAbhay Gupta is a mutual person
Dayal Fertilizers Private LimitedAman Kumar, Amrita Kumar and 2 more are mutual person
Dayal Farm Sciences Private LimitedAbhay Gupta is a mutual person
Charges (Loans)
₹0
₹40.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2014 | State Bank Of India | ₹4.00 Cr | Satisfied |
How Many Employees Work at Dayal Biotech?
Dayal Biotech has a workforce of 27 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dayal Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dayal Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.